Autoimmune Encephalitis in Brief
Abstract
No Abstract
Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis. Brain. 2004;127:701-12.
Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis. Ann Neurol. 2018;83:166-77.
Kelley BP, Patel SC, Marin HL, et al. Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis. AJNR Am J Neuroradiol. 2017;38:1070-8.
Armangue T. Autoimmune encephalitis in children. J Pediatr Neurol. 2017. DOI: 10.1055/s-0037-1604477
Leypoldt F and Wandinger KP. Paraneoplastic neurological syndromes. Clin Exp Immunol. 2014;175:336-48.
Daif A, Lukas RV, Issa NP, et al. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. Epilepsy & Behavior. 2018. DOI: https://doi.org/10.1016/j.yebeh.2018.01.021
Ramanathan S, Mohammad SS, Brilot F, et al. Autoimmune encephalitis: recent updates and emerging challenges. J Clin Neurosci. 2014;21:722-30.
Dubey D, Alqallaf A, Hays R, et al. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol. 2017;74:397-402.
Irani SR, Miller TD, Vincent A. Autoimmune encephalitis. In Oxford Textbook of Cognitive Neurology and Dementia. UK: Oxford University Press. 2016.
Gadoth A, Pittock SJ, Dubey D, et al. Expanded phenotypes and outcomes among 256 LGI1/CASPR2‐IgG positive patients. Ann Neurol. 2017;82:79-92.
Dubey D, Toledano M and McKeon A. Clinical presentation of autoimmune and viral encephalitides. Curr Opin Crit Care. 2018. DOI: https://doi.org/10.1097/MCC.0000000000000483.
Lancaster E and Dalmau J. Neuronal autoantigens—pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8:380-90.
Armangue T, Santamaria J and Dalmau J. When a serum test overrides the clinical assessment. Neurology. 2015;84:1379-81.
Höftberger R, Sepulveda M, Armangue T, et al.. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler. 2015;21:866-74.
Kothur K, Wienholt L, Mohammad SS, et al. Utility of CSF cytokine/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis. PloS one. 2016;11:e0161656.
Finke C, Kopp UA, Scheel M, et al. Functional and structural brain changes in anti–N‐methyl‐D‐aspartate receptor encephalitis. Ann Neurol. 2013;74:284-96.
Spatola M and Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis. Curr Opin Neurol. 2017;30:345-53.
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology. 2016;15:391-404.
Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016;12:1-3.
Haley M, Retter AS, Fowler D, et al. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin Infect Dis. 2003;37:e88-90.
| Files | ||
| Issue | Vol 57, No 2 (2019) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/acta.v57i2.1759 | |
| Keywords | ||
| No keywords#### | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
